PharmaCyte Biotech (PMCB) Depreciation & Amortization (CF) (2009 - 2012)
PharmaCyte Biotech's Depreciation & Amortization (CF) was $806.00 in fiscal Q4 2012 (quarter ended Apr 30, 2012), down 90.5% from $8,468 a year earlier and down 89.2% from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Depreciation & Amortization (CF) (2009 - 2012) Analysis & Trends
For FY2012 (ended Apr 30, 2012), Depreciation & Amortization (CF) at PharmaCyte Biotech came in at $24,659, down 39.4% from FY2011.
- In earlier fiscal years, Depreciation & Amortization (CF) was $40,688 in FY2011.
- The fiscal Q4 2012 figure marks the lowest quarterly Depreciation & Amortization (CF) in data going back to fiscal Q1 2011.
- Compared with a year earlier, Depreciation & Amortization (CF) has declined for four straight quarters, with an average decline of 41.7% over the last four quarters.
- Per Business Quant data, PMCB's Depreciation & Amortization (CF) in the three fiscal quarters before Q4 2012 was $7,473 (Q3 2012), $7,857 (Q2 2012) and $8,523 (Q1 2012).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 545.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.12 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 192.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 726.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.61 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 132.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.58 Bn |
| 10 | PharmaCyte Biotech | 4.29 Mn | -68.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2012 | 806.00 |
| Jan 31, 2012 | 7,473.00 |
| Oct 31, 2011 | 7,857.00 |
| Jul 31, 2011 | 8,523.00 |
| Apr 30, 2011 | 8,468.00 |
| Jan 31, 2011 | 9,232.00 |
| Oct 31, 2010 | 10,964.00 |
| Jul 31, 2010 | 12,024.00 |
| Apr 30, 2010 | 22,615.00 |
| Jan 31, 2010 | 27,184.00 |
| Oct 31, 2009 | 32,456.00 |
| Jul 31, 2009 | 32,657.00 |
| Apr 30, 2009 | 21,814.00 |
| Jan 31, 2009 | 2,292.00 |
API Access
PharmaCyte Biotech Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();